Kimberly Spano
Family · Belleville, ILNPI 1750927182
Payments from drug & device makers
Across 459 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Jazz Pharmaceuticals Inc.$813
- Harmony Biosciences LLC$745
- Regeneron Healthcare Solutions, Inc.$701
- Sanofi$596
- plus $3K from 25 others
What the payments were for
- Food & beverage$8,87698%
- Education$1602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 95 | $1,834 |
| GSK | 74 | $1,106 |
| Jazz Pharmaceuticals Inc. | 36 | $813 |
| Harmony Biosciences LLC | 24 | $745 |
| Regeneron Healthcare Solutions, Inc. | 24 | $701 |
| Sanofi | 24 | $596 |
| Electromed, Inc. | 55 | $489 |
| Boehringer Ingelheim | 25 | $455 |
| Axsome Therapeutics, Inc. | 11 | $221 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $197 |
| Insmed, Inc. | 9 | $183 |
| Grifols USA, LLC | 8 | $179 |
| Idorsia Pharmaceuticals US Inc | 4 | $156 |
| Teva Pharmaceuticals USA, Inc. | 7 | $144 |
| Mylan Specialty L.p. | 9 | $141 |
| United Therapeutics Corporation | 6 | $129 |
| Inspire Medical Systems, Inc. | 2 | $118 |
| Baxter Healthcare | 5 | $112 |
| Resmed Corp | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Merck | 4 | $93 |
| Johnson & Johnson(2 entities) | 5 | $86 |
| Actelion Pharmaceuticals US, Inc. | 3 | $77 |
| Shionogi Inc | 3 | $64 |
| Philips North America LLC | 3 | $49 |
| Pfizer | 2 | $33 |
| Boston Scientific | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| GE HealthCare | 1 | $26 |
| Viatris Specialty LLC | 1 | $18 |
| Itamar Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,036 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $36,030 |
| SunosiSolriamfetol Hcl | 14 | $12,617 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $9,083 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $6,100 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $4,585 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $3,026 |
| Ropinirole Hcl | 181 | $2,827 |
| Armodafinil | 14 | $2,426 |
| Modafinil | 33 | $1,947 |
| Fluticasone Propionate | 59 | $1,078 |
| Gabapentin | 54 | $608 |
| Montelukast Sodium | 48 | $438 |
| Zolpidem Tartrate | 48 | $317 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 17 | $165 |
| Trazodone Hcl | 16 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $1,106 | $51,21266 claims |
| Axsome Therapeutics, Inc.Sunosi | $221 | $12,61714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Belleville
- Amy BruggemannBelleville$88K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.